Zhang CZ - Search Results

1

Immune cell patterns before and after neoadjuvant immune checkpoint blockade combined with chemoradiotherapy in locally advanced esophageal squamous cell carcinoma.

Zheng DD, Li YY, Yuan XY, Lu JL, Zhang MF, Fu J, Zhang CZ. Zheng DD, et al. Among authors: zhang cz, zhang mf. BMC Cancer. 2024 May 27;24(1):649. doi: 10.1186/s12885-024-12406-3. BMC Cancer. 2024. PMID: 38802821 Free PMC article.

2

Downregulation of polo-like kinase 4 in hepatocellular carcinoma associates with poor prognosis.

Liu L, Zhang CZ, Cai M, Fu J, Chen GG, Yun J. Liu L, et al. Among authors: zhang cz. PLoS One. 2012;7(7):e41293. doi: 10.1371/journal.pone.0041293. Epub 2012 Jul 19. PLoS One. 2012. PMID: 22829937 Free PMC article.

3

Low SIRT3 expression correlates with poor differentiation and unfavorable prognosis in primary hepatocellular carcinoma.

Zhang CZ, Liu L, Cai M, Pan Y, Fu J, Cao Y, Yun J. Zhang CZ, et al. PLoS One. 2012;7(12):e51703. doi: 10.1371/journal.pone.0051703. Epub 2012 Dec 14. PLoS One. 2012. PMID: 23272146 Free PMC article.

4

Low cyclin F expression in hepatocellular carcinoma associates with poor differentiation and unfavorable prognosis.

Fu J, Qiu H, Cai M, Pan Y, Cao Y, Liu L, Yun J, Zhang CZ. Fu J, et al. Among authors: zhang cz. Cancer Sci. 2013 Apr;104(4):508-15. doi: 10.1111/cas.12100. Epub 2013 Feb 17. Cancer Sci. 2013. PMID: 23305207 Free PMC article.

5

Decrease of fibulin-3 in hepatocellular carcinoma indicates poor prognosis.

Luo R, Zhang M, Liu L, Lu S, Zhang CZ, Yun J. Luo R, et al. Among authors: zhang cz, zhang m. PLoS One. 2013 Aug 1;8(8):e70511. doi: 10.1371/journal.pone.0070511. Print 2013. PLoS One. 2013. PMID: 23936443 Free PMC article.

6

NORE1A sensitises cancer cells to sorafenib-induced apoptosis and indicates hepatocellular carcinoma prognosis.

Liu LL, Zhang MF, Pan YH, Yun JP, Zhang CZ. Liu LL, et al. Among authors: zhang cz, zhang mf. Tumour Biol. 2014 Mar;35(3):1763-74. doi: 10.1007/s13277-013-1184-2. Epub 2014 Feb 25. Tumour Biol. 2014. PMID: 24563371

7

FoxD3-regulated microRNA-137 suppresses tumour growth and metastasis in human hepatocellular carcinoma by targeting AKT2.

Liu LL, Lu SX, Li M, Li LZ, Fu J, Hu W, Yang YZ, Luo RZ, Zhang CZ, Yun JP. Liu LL, et al. Among authors: zhang cz. Oncotarget. 2014 Jul 15;5(13):5113-24. doi: 10.18632/oncotarget.2089. Oncotarget. 2014. PMID: 24970808 Free PMC article.

8

Pyruvate kinase M2 prevents apoptosis via modulating Bim stability and associates with poor outcome in hepatocellular carcinoma.

Hu W, Lu SX, Li M, Zhang C, Liu LL, Fu J, Jin JT, Luo RZ, Zhang CZ, Yun JP. Hu W, et al. Among authors: zhang cz, zhang c. Oncotarget. 2015 Mar 30;6(9):6570-83. doi: 10.18632/oncotarget.3262. Oncotarget. 2015. PMID: 25788265 Free PMC article.

9

Decrease of Bcl-xL/Bcl-2-associated death promoter in hepatocellular carcinoma indicates poor prognosis.

Hu W, Fu J, Lu SX, Liu LL, Luo RZ, Yun JP, Zhang CZ. Hu W, et al. Among authors: zhang cz. Am J Cancer Res. 2015 Apr 15;5(5):1805-13. eCollection 2015. Am J Cancer Res. 2015. PMID: 26175948 Free PMC article.

10

LRG1 expression indicates unfavorable clinical outcome in hepatocellular carcinoma.

Wang CH, Li M, Liu LL, Zhou RY, Fu J, Zhang CZ, Yun JP. Wang CH, et al. Among authors: zhang cz. Oncotarget. 2015 Dec 8;6(39):42118-29. doi: 10.18632/oncotarget.5967. Oncotarget. 2015. PMID: 26517349 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

431 results

Search Page

Filters